Divekar, Anagha A <br/><br/>
Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Dec 2011 
 - 293-303 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-7035 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2011.08.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, CD--analysis<br/>Benzamides<br/>Bronchoalveolar Lavage Fluid--immunology<br/>CD4-Positive T-Lymphocytes--drug effects<br/>Cell Adhesion Molecules--analysis<br/>Clinical Trials, Phase II as Topic<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Interleukin-4--immunology<br/>Lung--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Piperazines--therapeutic use<br/>Platelet Endothelial Cell Adhesion Molecule-1--analysis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Radiography<br/>Scleroderma, Systemic--diagnostic imaging